Cargando…

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene

β-globin gene disorders are the most prevalent inherited diseases worldwide and result from abnormal β-globin synthesis or structure. Novel therapeutic approaches are being developed in an effort to move beyond palliative management. Gene therapy, by ex vivo lentiviral transfer of a therapeutic β-gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Negre, Olivier, Eggimann, Anne-Virginie, Beuzard, Yves, Ribeil, Jean-Antoine, Bourget, Philippe, Borwornpinyo, Suparerk, Hongeng, Suradej, Hacein-Bey, Salima, Cavazzana, Marina, Leboulch, Philippe, Payen, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2016
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779296/ https://www.ncbi.nlm.nih.gov/pubmed/26886832 http://dx.doi.org/10.1089/hum.2016.007

Ejemplares similares

Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia
por: Nualkaew, Tiwaporn, et al.
Publicado: (2021)

Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies
por: Bhukhai, Kanit, et al.
Publicado: (2018)

Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
por: Negre, Olivier, et al.
Publicado: (2015)

Enhancement of β‐Globin Gene Expression in Thalassemic IVS2‐654 Induced Pluripotent Stem Cell‐Derived Erythroid Cells by Modified U7 snRNA
por: Phanthong, Phetcharat, et al.
Publicado: (2017)

Investigation of FoxO3 dynamics during erythroblast development in β-thalassemia major
por: Thanuthanakhun, Naruchit, et al.
Publicado: (2017)

Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line
por: Pongjantarasatian, Sarai, et al.
Publicado: (2019)

Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing
por: Fontana, Letizia, et al.
Publicado: (2023)

Curcumin inhibited hepatitis B viral entry through NTCP binding
por: Thongsri, Piyanoot, et al.
Publicado: (2021)

Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies
por: Venkatesan, Vigneshwaran, et al.
Publicado: (2023)

A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host
por: Sa-ngiamsuntorn, Khanit, et al.
Publicado: (2016)

Restoration of correct β(IVS2-654)-globin mRNA splicing and HbA production by engineered U7 snRNA in β-thalassaemia/HbE erythroid cells
por: Nualkaew, Tiwaporn, et al.
Publicado: (2019)

The Bioactive Peptide SL-13R Expands Human Umbilical Cord Blood Hematopoietic Stem and Progenitor Cells In Vitro
por: Nii, Takenobu, et al.
Publicado: (2021)

Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019)

Recent Approaches for Manipulating Globin Gene Expression in Treating Hemoglobinopathies
por: Mussolino, Claudio, et al.
Publicado: (2021)

An Immortalized Hepatocyte-Like Cell Line (imHC) Accommodated Complete Viral Lifecycle, Viral Persistence Form, cccDNA and Eventual Spreading of a Clinically-Isolated HBV
por: Sa-ngiamsuntorn, Khanit, et al.
Publicado: (2019)

Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with PKD1 Mutation
por: Linn, Aung Khine, et al.
Publicado: (2022)

Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018)

Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
por: Srimongkol, Atthapol, et al.
Publicado: (2023)

Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies
por: Loucari, Constantinos C., et al.
Publicado: (2018)

Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study
por: Chupradit, Koollawat, et al.
Publicado: (2022)

A method to sequence and quantify DNA integration for monitoring outcome in gene therapy
por: Brady, Troy, et al.
Publicado: (2011)

Upregulation of CYP 450s expression of immortalized hepatocyte-like cells derived from mesenchymal stem cells by enzyme inducers
por: Sa-ngiamsuntorn, Khanit, et al.
Publicado: (2011)

Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir
por: Kongsomros, Supasek, et al.
Publicado: (2021)

Prenatal Diagnosis of β-Thalassemias and Hemoglobinopathies.
por: Rosatelli, Maria Cristina, et al.
Publicado: (2009)

Careful adjustment of Epo non-viral gene therapy for β-thalassemic anaemia treatment
por: Fabre, Emmanuelle E, et al.
Publicado: (2008)

The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
por: Rattananon, Parin, et al.
Publicado: (2021)

PGE2 and Poloxamer Synperonic F108 Enhance Transduction of Human HSPCs with a β-Globin Lentiviral Vector
por: Masiuk, Katelyn E., et al.
Publicado: (2019)

Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences
por: Morgan, Richard A., et al.
Publicado: (2020)

β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion Production
por: Han, Jiaying, et al.
Publicado: (2020)

A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax
por: Pewkliang, Yongyut, et al.
Publicado: (2018)

Animal models of β-hemoglobinopathies: utility and limitations
por: McColl, Bradley, et al.
Publicado: (2016)

Unexpected discovery of hemoglobinopathy C/β° thalassemia
por: Bouyarmane, Wafaa, et al.
Publicado: (2018)

Genome Editing for β-Hemoglobinopathies: Advances and Challenges
por: Frati, Giacomo, et al.
Publicado: (2021)

Design of a trans protease lentiviral packaging system that produces high titer virus
por: Westerman, Karen A, et al.
Publicado: (2007)

The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cells
por: Romero, Zulema, et al.
Publicado: (2015)

Enhancing Erythropoiesis by a Phytoestrogen Diarylheptanoid from Curcuma comosa
por: Bhukhai, Kanit, et al.
Publicado: (2022)

Gene therapy for severe combined immunodeficiencies and beyond
por: Fischer, Alain, et al.
Publicado: (2019)

The phenomena of balanced effect between α-globin gene and of β-globin gene
por: Zhong, Liangying, et al.
Publicado: (2018)

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
por: Poletti, Valentina, et al.
Publicado: (2018)

Genomic approaches to identifying targets for treating β hemoglobinopathies
por: Ngo, Duyen A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_02n51ma4158ic268ns0gag29ql